Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease
Conditions: Anemia; Chronic Kidney Disease; Kidney DiseaseInterventions: Drug: darbepoetin alfa QW; Drug: darbepoetin alfa Q2WSponsor: AmgenTerminated - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Aranesp | Chronic Kidney Disease | Pediatrics | Research | Study | Urology & Nephrology